Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 16 results

Filters: Author is Logan, Brent R [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Levine, John E, Brent R Logan, Juan Wu, Amin M Alousi, Javier Bolaños-Meade, James LM Ferrara, Vincent T Ho, Daniel J Weisdorf, and Sophie Paczesny. 2012. “Acute Graft-Versus-Host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: A Blood And Marrow Transplant Clinical Trials Network Study.”. Blood 119 (16). Blood: 3854-60. doi:10.1182/blood-2012-01-403063.

E

Alousi, Amin M, Daniel J Weisdorf, Brent R Logan, Javier Bolaños-Meade, Shelly Carter, Nancy DiFronzo, Marcelo Pasquini, et al.. 2009. “Etanercept, Mycophenolate, Denileukin, Or Pentostatin Plus Corticosteroids For Acute Graft-Versus-Host Disease: A Randomized Phase 2 Trial From The Blood And Marrow Transplant Clinical Trials Network.”. Blood 114 (3). Blood: 511-7. doi:10.1182/blood-2009-03-212290.

G

Martens, Michael J, and Brent R Logan. 2018. “A Group Sequential Test For Treatment Effect Based On The Fine-Gray Model.”. Biometrics 74 (3). Biometrics: 1006-1013. doi:10.1111/biom.12871.

Martens, Michael J, and Brent R Logan. 2020. “Group Sequential Tests For Treatment Effect On Survival And Cumulative Incidence At A Fixed Time Point.”. Lifetime Data Anal 26 (3). Lifetime Data Anal: 603-623. doi:10.1007/s10985-019-09491-z.

I

Waller, Edmund K, Brent R Logan, Wayne AC Harris, Steven M Devine, David L Porter, Shin Mineishi, John M McCarty, et al.. 2014. “Improved Survival After Transplantation Of More Donor Plasmacytoid Dendritic Or Naïve T Cells From Unrelated-Donor Marrow Grafts: Results From Bmtctn 0201.”. J Clin Oncol 32 (22). J Clin Oncol: 2365-72. doi:10.1200/JCO.2013.54.4577.

Young, Jo-Anne H, Brent R Logan, Juan Wu, John R Wingard, Daniel J Weisdorf, Cathryn Mudrick, Kristin Knust, et al.. 2016. “Infections After Transplantation Of Bone Marrow Or Peripheral Blood Stem Cells From Unrelated Donors.”. Biol Blood Marrow Transplant 22 (2). Biol Blood Marrow Transplant: 359-370. doi:10.1016/j.bbmt.2015.09.013.

L

Bolaños-Meade, Javier, Juan Wu, Brent R Logan, John E Levine, Vincent T Ho, Amin M Alousi, Daniel J Weisdorf, and Leo Luznik. 2013. “Lymphocyte Phenotype During Therapy For Acute Graft-Versus-Host Disease: A Brief Report From Bmt-Ctn 0302.”. Biol Blood Marrow Transplant 19 (3). Biol Blood Marrow Transplant: 481-5. doi:10.1016/j.bbmt.2012.12.003.

M

Scott, Bart L, Marcelo C Pasquini, Brent R Logan, Juan Wu, Steven M Devine, David L Porter, Richard T Maziarz, et al.. 2017. “Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation For Acute Myeloid Leukemia And Myelodysplastic Syndromes.”. J Clin Oncol 35 (11). J Clin Oncol: 1154-1161. doi:10.1200/JCO.2016.70.7091.

P

Anasetti, Claudio, Brent R Logan, Stephanie J Lee, Edmund K Waller, Daniel J Weisdorf, John R Wingard, Corey S Cutler, et al.. 2012. “Peripheral-Blood Stem Cells Versus Bone Marrow From Unrelated Donors.”. N Engl J Med 367 (16). N Engl J Med: 1487-96. doi:10.1056/NEJMoa1203517.

Bolaños-Meade, Javier, Brent R Logan, Amin M Alousi, Joseph H Antin, Kate Barowski, Shelly L Carter, Steven C Goldstein, et al.. 2014. “Phase 3 Clinical Trial Of Steroids/mycophenolate Mofetil Vs Steroids/placebo As Therapy For Acute Gvhd: Bmt Ctn 0802.”. Blood 124 (22). Blood: 3221-7; quiz 3335. doi:10.1182/blood-2014-06-577023.

Carpenter, Paul A, Brent R Logan, Stephanie J Lee, Daniel J Weisdorf, Laura Johnston, Luciano J Costa, Carrie L Kitko, et al.. 2018. “A Phase Ii/iii Randomized, Multicenter Trial Of Prednisone/sirolimus Prednisone/ Sirolimus/calcineurin Inhibitor For The Treatment Of Chronic Graft--Host Disease: Bmt Ctn 0801.”. Haematologica 103 (11). Haematologica: 1915-1924. doi:10.3324/haematol.2018.195123.

Zaid, Mohammad Abu, Juan Wu, Cindy Wu, Brent R Logan, Jeffrey Yu, Corey Cutler, Joseph H Antin, Sophie Paczesny, and Sung Won Choi. 2017. “Plasma Biomarkers Of Risk For Death In A Multicenter Phase 3 Trial With Uniform Transplant Characteristics Post-Allogeneic Hct.”. Blood 129 (2). Blood: 162-170. doi:10.1182/blood-2016-08-735324.

R

Yanik, Gregory A, Mary M Horowitz, Daniel J Weisdorf, Brent R Logan, Vincent T Ho, Robert J Soiffer, Shelly L Carter, et al.. 2014. “Randomized, Double-Blind, Placebo-Controlled Trial Of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) For The Treatment Of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: Blood And Marrow Transplant Clinical Trials Ne”. Biol Blood Marrow Transplant 20 (6). Biol Blood Marrow Transplant: 858-64. doi:10.1016/j.bbmt.2014.02.026.

Pidala, Joseph, Mehdi Hamadani, Peter Dawson, Michael Martens, Amin M Alousi, Madan Jagasia, Yvonne A Efebera, et al.. 2020. “Randomized Multicenter Trial Of Sirolimus Vs Prednisone As Initial Therapy For Standard-Risk Acute Gvhd: The Bmt Ctn 1501 Trial.”. Blood 135 (2). Blood: 97-107. doi:10.1182/blood.2019003125.

T

Bolaños-Meade, Javier, Ran Reshef, Raphael Fraser, Mingwei Fei, Sunil Abhyankar, Zaid Al-Kadhimi, Amin M Alousi, et al.. 2019. “Three Prophylaxis Regimens (Tacrolimus, Mycophenolate Mofetil, And Cyclophosphamide; Tacrolimus, Methotrexate, And Bortezomib; Or Tacrolimus, Methotrexate, And Maraviroc) Versus Tacrolimus And Methotrexate For Prevention Of Graft-Versus-Host Disease With”. Lancet Haematol 6 (3). Lancet Haematol: e132-e143. doi:10.1016/S2352-3026(18)30221-7.

Shenoy, Shalini, Mary Eapen, Julie A Panepinto, Brent R Logan, Juan Wu, Allistair Abraham, Joel Brochstein, et al.. 2016. “A Trial Of Unrelated Donor Marrow Transplantation For Children With Severe Sickle Cell Disease.”. Blood 128 (21). Blood: 2561-2567. doi:10.1182/blood-2016-05-715870.